.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

SWASTHFIT TAX SAVER BASIC PACKAGE

HEMOGRAM
(DC Detection, Flow Cytometry, SLS, & Capillary photometry)
Hemoglobin 14.70 g/dL 13.00 - 17.00

Packed Cell Volume (PCV) 48.20 % 40.00 - 50.00

RBC Count 5.52 mill/mm3 4.50 - 5.50

MCV 87.30 fL 83.00 - 101.00

Mentzer Index 15.8

MCH 26.60 pg 27.00 - 32.00

MCHC 30.50 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 15.40 % 11.60 - 14.00

Total Leukocyte Count (TLC) 7.66 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 49.70 % 40.00 - 80.00

Lymphocytes 39.40 % 20.00 - 40.00

Monocytes 6.50 % 2.00 - 10.00

Eosinophils 3.90 % 1.00 - 6.00

Basophils 0.50 % <2.00

Absolute Leucocyte Count

Neutrophils 3.81 thou/mm3 2.00 - 7.00

Lymphocytes 3.02 thou/mm3 1.00 - 3.00

Monocytes 0.50 thou/mm3 0.20 - 1.00

*466581794* Page 1 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

Eosinophils 0.30 thou/mm3 0.02 - 0.50

Basophils 0.04 thou/mm3 0.02 - 0.10

Platelet Count 201 thou/mm3 150.00 - 410.00

Mean Platelet Volume 13.3 fL 6.5 - 12.0

E.S.R. 2 mm/hr 0 - 15

Comment
In anaemic conditions Mentzer index is used to differentiate Iron Deficiency Anaemia from Beta- Thalassemia
trait. If Mentzer Index value is >13, there is probability of Iron Deficiency Anaemia. A value <13 indicates likelihood
of Beta- Thalassemia trait and Hb HPLC is advised to rule out the Thalassemia trait.

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

*466581794* Page 2 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

LIVER & KIDNEY PANEL, SERUM

Creatinine 0.83 mg/dL 0.67 - 1.17

(Compensated Jaffes reaction, IDMS traceable)
GFR Estimated 130 mL/min/1.73m2 >59

GFR Category G1

Urea 25.90 mg/dL 17.00 - 43.00

(Urease UV)
Urea Nitrogen Blood 12.10 mg/dL 6.00 - 20.00

BUN/Creatinine Ratio 15

Uric Acid 6.40 mg/dL 3.50 - 7.20

(Uricase)
AST (SGOT) 44.0 U/L <50
(IFCC without P5P)
ALT (SGPT) 76.0 U/L <50
(IFCC without P5P)
GGTP 28.0 U/L <55
(IFCC)
Alkaline Phosphatase (ALP) 138.00 U/L 30 - 120
(IFCC, AMP BUFFER)
Bilirubin Total 0.52 mg/dL 0.30 - 1.20
(DPD)
Bilirubin Direct 0.11 mg/dL <0.20
(DPD)
Bilirubin Indirect 0.41 mg/dL <1.10
(Calculated)
Total Protein 6.95 g/dL 6.00 - 8.00
(Biuret)
Albumin 4.41 g/dL 3.50 - 5.20
(BCG)
A : G Ratio 1.74 0.90 - 2.00
(Calculated)
Globulin(Calculated) 2.54 gm/dL 2.0 - 3.5

Calcium, Total 9.01 mg/dL 8.60 - 10.30

(Arsenazo III)

*466581794* Page 3 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

Phosphorus 4.50 mg/dL 2.40 - 4.40
(Molybdate UV)
Sodium 136.30 mEq/L 136.00 - 146.00
(Indirect ISE)
Potassium 5.36 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 101.60 mEq/L 101.00 - 109.00
(Indirect ISE)

Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1

LIPID SCREEN, SERUM

Cholesterol, Total 183.00 mg/dL <200.00

(CHO-POD)
Triglycerides 178.00 mg/dL <150.00
(GPO-POD)
HDL Cholesterol 45.00 mg/dL >40.00
(Enz Immunoinhibition)
LDL Cholesterol, Calculated 102.40 mg/dL <100.00
(Calculated)
VLDL Cholesterol,Calculated 35.60 mg/dL <30.00
(Calculated)
Non-HDL Cholesterol 138 mg/dL <130
(Calculated)

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
3. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for

*466581794* Page 4 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors
4. Indians tend to have higher triglyceride levels & Lower HDL cholesterol combined with small dense
LDL particles, a pattern known as atherogenic dyslipidemia
5. Non HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL,
VLDL & VLDL remnants, Chylomicron remnants & Lp(a)
6. LAI recommends LDL cholesterol as primary target and Non HDL cholesterol as co-primary treatment
target
7. Apolipoprotein B is an, secondary lipid target for treatment once LDL & Non HDL goals have been
achieved
8. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered among
patients with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category B | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at
least 3 months

*466581794* Page 5 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP Certified)

HbA1c 5.6 % 4.00 - 5.60

Estimated average glucose (eAG) 114 mg/dL

Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*466581794* Page 6 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA 88.00 mg/dL 70.00 - 100.00

(Hexokinase)

*466581794* Page 7 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

FERRITIN, SERUM
(CLIA)

Ferritin 97.40 ng/mL 22.00 - 322.00

Note: Increase in serum ferritin due to inflammatory conditions (Acute phase response) can mask a
diagnostically low result

Comments
Serum ferritin appears to be in equilibrium with tissue ferritin and is a good indicator of storage iron in normal
subjects and in most disorders. In patients with some hepatocellular diseases, malignancies and inflammatory
diseases, serum ferritin is a disproportionately high estimate of storage iron because serum ferritin is an
acute phase reactant. In such disorders iron deficiency anemia may exist with a normal serum ferritin
concentration. In the presence of inflammation, persons with low serum ferritin are likely to respond to iron
therapy.

Increased Levels
· Iron overload - Hemochromatosis, Thalassemia & Sideroblastic anemia
· Malignant conditions - Acute myeloblastic & Lymphoblastic leukemia, Hodgkin’s disease & Breast
carcinoma
· Inflammatory diseases - Pulmonary infections, Osteomyelitis, Chronic UTI, Rheumatoid arthritis, SLE,
burns
· Acute & Chronic hepatocellular disease

Decreased Levels
Iron deficiency anemia

THYROID PROFILE,TOTAL, SERUM

(CLIA)
T3, Total 1.09 ng/mL 0.86 - 1.92

T4, Total 5.60 µg/dL 5.50 - 11.10

TSH 1.81 µIU/mL 0.70 - 6.40

*466581794*
Page 8 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

*466581794*
Page 9 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

IRON STUDIES, SERUM

(TPTZ)
Iron 75.00 µg/dL 65.00 - 175.00

Total Iron Binding Capacity (TIBC) 416.00 µg/dL 250.00 - 425.00

Transferrin Saturation 18.03 % 20.00 - 50.00

Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

*466581794*
Page 10 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)

Gross Examination

Colour Lemon Yellow Pale yellow

Specific Gravity 1.030 1.001 - 1.030

pH 5 5.0 - 8.0

Proteins Negative Negative

Glucose Negative Negative

Ketones Negative Negative

Bilirubin Negative Negative

Urobilinogen Negative Negative

Blood Negative Negative

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

Microscopy

R.B.C. Negative 0-2 RBC/hpf

Pus Cells 3-4 WBC/HPF 0-5 WBC / hpf

Epithelial Cells 2-3 Epi Cells/hpf 0-5 Epi cells/hpf

Casts None seen None seen/Lpf

Crystals None seen None seen

Others None seen None seen

*466581794*
Page 11 of 12
.

Name : Mr. SAMARPAN MOHANTY

Lab No. : 466581794 Age : 18 Years
Ref By : SELF Gender : Male
Collected : 16/7/2024 10:07:00AM Reported : 16/7/2024 2:54:11PM
A/c Status : P Report Status : Final
Collected at : MRS.BINA FPSC 21-D (FARIDABAD) Processed at : LPL-FARIDABAD
SCO-06, 2nd Floor, Sector-16, Faridabad,
Haryana-121002

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Rachna Malik
MD, Pathology
Consultant Pathologist
Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIFPHNLGHIGIJCBILLJCECCKLCIKPLNKEDFEFAPPAHEEEHA
BNFFFNBPAPBDEGBGFGELIOAPAOAHFHALBKNOBCJKFLELNOJGMPBNFFFNB
GMDAHBFPJNONBHGNHFIAAJHFJEDEHEDBJKPHENFLMKLMOEFLBLHDEHANP
DJNBAGFNBNBIELEMNKNELEPFANPLBKAFJIFEPBPAKKNJPDNLILPBKEMEL
JADNJLFIOFJFDIACPAHGMHBILENNKBIHKKMNEKMIPLKGKPNGKFFFOLINH
DPCBBEFDOECAMJEKIAFIPIPBADHFOFAINDECBKDLALIKOMNALNEJPGMCL
DBIMIJFNELONBPBIEOIGJHEHIHAFJBALOFGPBLMMOJCHKNFMIJNNIDILD
BNFNAMFMAJNMHMKMAANHDCMILKBMFMBHOFCCAMNNIJKDKPNGBNFMBHILL
NKFHBOFHPCDGFEIOEMMIHNJKHEOFEKFBJFFKBLOFOEBIOCNKDJPHNEKLJ
NMGBNCFCELMJJDCJHNLOIDJKBDFKPNJHKEPPCDNLNKCKIGEOCEHKHPAIK
BGIKNMFLGKKKNOCMPIENIJEEINMFPJJBJNEEBFOFPNDMKPFKEPCIGCIMO
MGICGJFMMLDIMAGMHPCFAPCEIEOPPFOEBKNPBLNOOLJAIANINKONHDICL
MNNNNNEHCEDLEOIAGCFLHFAHJBAHFHAHLKPFCMNLMKJIPFNNAHFHAHIKL
APBBBPAPBPPAEBFFLNBKCAMFAGFCHHCAONFFPLOGOLMHNLNFEDFHCBKHH
HHHHHHHPHHHPHPPHHHPPPHPPPHPPPPPPPPPHHPHPPHHHPHPHHHHHPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

*466581794*
Page 12 of 12